Nutanix (NTNX)
(Delayed Data from NSDQ)
$54.28 USD
-2.42 (-4.27%)
Updated Jul 12, 2024 04:00 PM ET
After-Market: $54.28 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
D Value A Growth A Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$54.28 USD
-2.42 (-4.27%)
Updated Jul 12, 2024 04:00 PM ET
After-Market: $54.28 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
D Value A Growth A Momentum A VGM
Zacks News
Nutanix (NTNX) Posts Narrower Loss in Q2, Revenues Up Y/Y
by Zacks Equity Research
Nutanix (NTNX) second-quarter results benefit from expanding clientele and strong partner base.
Nutanix (NTNX) Catches Eye: Stock Jumps 7.4%
by Zacks Equity Research
Nutanix (NTNX) was a big mover last session, as the company saw its shares rise more than 7% on the day.
MasTec, NutriSystem and Nutanix highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
MasTec, NutriSystem and Nutanix highlighted as Zacks Bull and Bear of the Day
Nutanix (NTNX) Tops Q2 Earnings & Revenue Estimates
by Benjamin Rains
Nutanix, Inc. (NTNX) just released its second-quarter fiscal 2018 financial results, posting an adjusted loss of $0.14 per share and revenues of $286.7 million.
Should You Sell Nutanix (NTNX) Before Earnings?
by Zacks Equity Research
Nutanix (NTNX) is seeing encouraging earnings estimate revision activity as of late and carries a favorable rank, positioning the company for a likely beat this season.
Nutanix (NTNX) to Report Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Nutanix (NTNX) second-quarter fiscal 2018 results are likely to gain from an expanding clientele driven by an enriched portfolio.
6 Technology Stocks Poised to Beat Estimates in Q4 Earnings
by Zacks Equity Research
Here are six technology stocks that are likely to deliver positive earnings surprise this earnings season.
Waters' (WAT) Q4 Earnings Beat on Broad-Based Sales Growth
by Zacks Equity Research
Waters Corp.'s (WAT) fourth-quarter 2017 earnings beat driven by broad-based top-line expansion, along with spectacular growth in Europe.
Amdocs (DOX) Debuts on 5G-Ready Online Charging System
by Zacks Equity Research
Amdocs Limited (DOX) aims to help service providers effectively monetize 5G network with its recently upgraded digital monetization solution.
Nutanix Plans Senior Notes Offering Due to Mature in 2023
by Zacks Equity Research
Nutanix (NTNX) intends to use the net proceeds from the planned offering to pay for its convertible note hedge transactions and other general corporate purposes.
Infosys (INFY) in Focus: Stock Moves 5.8% Higher
by Zacks Equity Research
Infosys (INFY) saw a big move last session, as its shares jumped nearly 6% on the day, amid huge volumes.
Infosys (INFY) Beats on Q3 Earnings & Revenues, View Intact
by Zacks Equity Research
Infosys (INFY) has braved formidable odds like contracted IT spending and unfavorable political climate in the United States to score earnings beat in third-quarter fiscal 2018.
Infosys to Support Proximus' IT Transformation with Excite
by Zacks Equity Research
Infosys (INFY) is chosen by Proximus, the largest telecommunications company of Belgium, to implement Excite to strengthen the Proximus' IT capabilities.
Infosys Teams Up With ValGenesis to Improve Digitization
by Zacks Equity Research
Infosys (INFY) announces collaboration with ValGenesis to bring a stronger compliance and quality management for customers in the healthcare and life sciences sectors.
ViaSat Set to Upgrade NATO UHF SATCOM Control Stations
by Zacks Equity Research
ViaSat (VSAT) wins a deal to upgrade the NATO UHF satellite communications ("SATCOM") control stations.
Here's Why Investing In Waters Corp (WAT) Now Makes Sense
by Zacks Equity Research
Steady demand from pharmaceutical business, solid recurring revenues and modest recovery in industrial markets are proving conducive to Waters Corp's (WAT) impressive performance.
Infosys (INFY) BPO Subsidiary Secures Consent to Change Name
by Zacks Equity Research
Infosys Limited's (INFY) Business Process Outsourcing subsidiary, Infosys BPO, changes name to Infosys BPM Limited. The modification is in sync with the shift in its service-providing approach.
Uber's Road to IPO: Will It Live Up to the Hype?
by Madeleine Johnson
Without a doubt, investors are eagerly awaiting an Uber IPO. Thanks to its structure--a unique combination of transportation company, mobile Internet company, and real-world engineering--the company has been touted as one of the best future market debuts. But can it live up to the hype?
Science Applications (SAIC) Beats Q3 Earnings Estimates
by Zacks Equity Research
Science Applications' (SAIC) third-quarter fiscal 2018 results benefit from higher revenues on new contracts supporting NASA, the U.S. Army and EPA.
Nutanix (NTNX) Looks Bright Post Q1 Earnings: Time to Buy?
by Zacks Equity Research
Nutanix Inc. (NTNX) is one such technology stock that has been on healthy growth trajectory, of late.
Company News For Dec 4, 2017
by Zacks Equity Research
Companies In The News are: AMWD,AMBA,NTNX,ULTA
Nutanix (NTNX) Looks Good: Stock Adds 9.9% in Session
by Zacks Equity Research
Nutanix (NTNX) shares rose nearly 10% in the last trading session, amid huge volumes.
Nutanix's (NTNX) Q1 Loss Narrower Than Expected, Stock Up
by Zacks Equity Research
Nutanix's (NTNX) first-quarter fiscal 2018 earnings benefit from expanding customer base, strong billings and lower operating expenses.
The Zacks Analyst Blog Highlights: Ulta Beauty, VMware, Nutanix, Zumiez and Five Below
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Ulta Beauty, VMware, Nutanix, Zumiez and Five Below
Q3 Results for Specialty Retail Continue
by Mark Vickery
Ulta, Five Below, Nutanix, VMware and Zumiez all put up new quarterly results after the bell today, with a wide range of results.